Long-term パチスロ 化 物語 フリーズ “パチスロ 化 物語 フリーズ 110” is divided into three stages (Stage1: FY2023-FY2025, Stage2: FY2026 -FY2029, and Stage3: FY2030-FY2032). Statement in パチスロ 化 物語 フリーズ 110-Stage1- is "transforming into the business structure to realize パチスロ 化 物語 フリーズ 110", and the following five business strategies will be promoted with the aim of achieving performance targets and improving support and evaluations from stakeholders.
- 1Strengthening drug discovery capability to create high-value new drugs that meet medical needs
- 2Expansion of development pipeline through in-licensing
- 3Maximization of the ratio of new drugs
- 4Promoting healthcare-related businesses that have synergies with the new drugs business
- 5Building a sustainable corporate foundation
Strategy
New drugs business
Drug Discovery
Reorganization
Creation of new drugs from long-term perspective
Strengthen the drug discovery capability to create high-value new drugs that meet medical needs
- Try for drug innovation through new drug discovery strategies
Development
Investment of resource
Enhancement of development pipeline
Expansion of development pipeline through in-licensing
- Significantly strengthen in-licensing ability
- Promote DTx development
Marketing, SCM, Reliability Assurance
Driving force of revenue
Maximization of profitability
Maximization of the ratio of new drugs
- Maximize the extension of new drugs
- Ensure the stable supply of high-quality drugs
Healthcare-related business
GE business
- Achieve sustainable growth in the generic drugs business
- Strengthen production capacity for drugs and reduce manufacturing costs
Other business
- Promote infectious disease-related business